Grasemann H, Wiesemann H G, Ratjen F
Zentrum für Kinder- und Jugendmedizin der Universität--Gesamthochschule Essen.
Pneumologie. 1995 Aug;49(8):466-9.
Prediction of mortality in cystic fibrosis (CF) has become an important issue in the era of lung transplantation. A study from Toronto has shown a forced expiratory volume in one second (FEV1) below 30% predicted to be the best predictor of two-year mortality. The purpose of this investigation was to assess whether these data are relevant for other CF centers with a different overall life expectancy. We have analysed pulmonary function tests (PFTs) obtained in our population of CF patients between 1979 and 1991. 19 of the 73 patients included in this analysis had died. Cox proportional hazard regression analysis was performed using the lung function parameters as single covariates. In addition results of PFTs obtained two years before death were compared to similarly lagged values of surviving patients. Inspiratory vital capacity (IVC) (p < 0.0001), the ratio of residual volume/total lung capacity (RV/TLC) (p < 0.0001), forced expiratory volume in one second (FEV1) (p < 0.0002), specific conductance (sGaw) (p < 0.025) and a weight for height below the third percentile (p < 0.023) were significant predictors of two-year mortality. Two-year mortality were 50% for a FEV1 < 30% predicted and 47% for a RV/TLC ratio > 50%. Our data confirm that a FEV1 < 30% and a RV/TLC ratio > 50% are significant predictors of mortality in CF. However, interindividual variability in survival with a FEV1 < 30% is high. The decision for lung transplantation can therefore not be based on pulmonary function alone.
在肺移植时代,预测囊性纤维化(CF)患者的死亡率已成为一个重要问题。多伦多的一项研究表明,一秒用力呼气容积(FEV1)低于预测值的30%是预测两年死亡率的最佳指标。本研究的目的是评估这些数据是否适用于其他总体预期寿命不同的CF中心。我们分析了1979年至1991年间在我们的CF患者群体中获得的肺功能测试(PFT)结果。本分析纳入的73例患者中有19例死亡。使用肺功能参数作为单一协变量进行Cox比例风险回归分析。此外,将死亡前两年获得的PFT结果与存活患者类似的滞后值进行比较。吸气肺活量(IVC)(p<0.0001)、残气量/肺总量比值(RV/TLC)(p<0.0001)、一秒用力呼气容积(FEV1)(p<0.0002)、比气道传导率(sGaw)(p<0.025)以及身高体重低于第三百分位数(p<0.023)是两年死亡率的显著预测指标。预测FEV1<30%时两年死亡率为50%,RV/TLC比值>50%时为47%。我们的数据证实,FEV1<30%和RV/TLC比值>50%是CF患者死亡率的显著预测指标。然而,FEV1<30%时个体间的生存差异很大。因此,肺移植的决策不能仅基于肺功能。